• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染患者应用不同评分系统的房颤与心血管风险评估。

Atrial Fibrillation and Cardiovascular Risk Assessment among COVID-19 Patients Using Different Scores.

机构信息

From Bridgeport Hospital/Yale New Haven Health, Bridgeport, Connecticut, the University of Tennessee College of Medicine, Memphis, the Department of Neurology, National Institute of Neurosciences and Hospital, Dhaka, Bangladesh, and Department of Cardiology, National Institute of Cardiovascular Diseases and Hospital, Dhaka, Bangladesh.

出版信息

South Med J. 2022 Dec;115(12):921-925. doi: 10.14423/SMJ.0000000000001477.

DOI:10.14423/SMJ.0000000000001477
PMID:36455902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9696680/
Abstract

Since the advent of severe acute respiratory syndrome-coronavirus-2 in December 2019, millions of people have been infected and succumbed to death because of this deadly virus. Cardiovascular complications such as thromboembolism and arrhythmia are predominant causes of morbidity and mortality. Different scores previously used for atrial fibrillation (AF) identification or prediction of its complications were investigated by physicians to understand whether those scores can predict in-hospital mortality or AF among patients infected with the severe acute respiratory syndromecoronavirus-2 virus. Using such scores gives hope for early prediction of atrial arrhythmia and in-hospital mortality among coronavirus disease 2019-infected patients. We have discussed the mechanisms of AF and cardiovascular damage in coronavirus disease 2019 patients, different methods of AF prediction, and compared different scores for prediction of in-hospital mortality after this viral infection.

摘要

自 2019 年 12 月严重急性呼吸综合征冠状病毒 2 型出现以来,全球已有数百万人感染并因此致命病毒而死亡。血栓栓塞和心律失常等心血管并发症是发病率和死亡率的主要原因。医生研究了先前用于房颤(AF)识别或预测其并发症的不同评分,以了解这些评分是否可以预测感染严重急性呼吸综合征冠状病毒-2 病毒的患者的住院死亡率或房颤。使用这些评分有望早期预测感染冠状病毒 2019 患者的心房性心律失常和住院死亡率。我们讨论了在 2019 年冠状病毒病患者中房颤和心血管损害的机制,房颤预测的不同方法,并比较了这种病毒感染后预测住院死亡率的不同评分。

相似文献

1
Atrial Fibrillation and Cardiovascular Risk Assessment among COVID-19 Patients Using Different Scores.新冠病毒感染患者应用不同评分系统的房颤与心血管风险评估。
South Med J. 2022 Dec;115(12):921-925. doi: 10.14423/SMJ.0000000000001477.
2
Association of atrial fibrillation with infectivity and severe complications of COVID-19: A nationwide cohort study.心房颤动与新型冠状病毒肺炎感染性及严重并发症的关联:一项全国性队列研究。
J Med Virol. 2022 Jun;94(6):2422-2430. doi: 10.1002/jmv.27647. Epub 2022 Feb 17.
3
[Is atrial fibrillation an independent marker of cardiovascular risk?].[心房颤动是心血管风险的独立标志物吗?]
Ann Cardiol Angeiol (Paris). 2010 Dec;59 Suppl 1:S14-8. doi: 10.1016/S0003-3928(10)70003-2.
4
CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study.CHA2DS2-VASc、ATRIA、Essen 卒中风险评分与非瓣膜性心房颤动相关性卒中:一项全国多中心注册研究。
Medicine (Baltimore). 2021 Jan 22;100(3):e24000. doi: 10.1097/MD.0000000000024000.
5
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study.心房颤动对住院 COVID-19 患者临床病程和结局的影响:Cardio-COVID-Italy 多中心研究结果。
Europace. 2021 Oct 9;23(10):1603-1611. doi: 10.1093/europace/euab146.
6
Clinical risk scores for the prediction of incident atrial fibrillation: a modernized review.临床风险评分预测心房颤动事件:现代化综述。
Rom J Intern Med. 2021 Nov 20;59(4):321-327. doi: 10.2478/rjim-2021-0018. Print 2021 Dec 1.
7
Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry.在常规临床实践中阵发性、持续性和永久性心房颤动的分布和风险特征:来自真实世界全球调查评估心房颤动国际登记研究的见解。
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9. doi: 10.1161/CIRCEP.112.970749. Epub 2012 Jul 11.
8
Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study.二尖瓣环钙化可预测伴心房颤动的中年患者的心血管发病率和死亡率:贝尔格莱德心房颤动研究。
Chest. 2011 Oct;140(4):902-910. doi: 10.1378/chest.10-2963. Epub 2011 Mar 24.
9
New-Onset Atrial Fibrillation in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry.COVID-19 住院患者新发心房颤动:美国心脏协会 COVID-19 心血管登记研究结果。
Circ Arrhythm Electrophysiol. 2022 May;15(5):e010666. doi: 10.1161/CIRCEP.121.010666. Epub 2022 Apr 27.
10
Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19.与 COVID-19 住院患者的心房心律失常相关的结局和死亡率。
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3077-3085. doi: 10.1111/jce.14770. Epub 2020 Oct 14.

本文引用的文献

1
The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19.ATRIA 评分优于 m-CHA2DS2-Vasc 评分,可预测 COVID-19 患者住院期间的死亡率。
Rev Assoc Med Bras (1992). 2021 Mar;67(3):443-448. doi: 10.1590/1806-9282.20200983.
2
Admission Braden Scale Score as an Early Independent Predictor of In-Hospital Mortality Among Inpatients With COVID-19: A Retrospective Cohort Study.Braden 量表评分作为 COVID-19 住院患者院内死亡率的早期独立预测指标:一项回顾性队列研究。
Worldviews Evid Based Nurs. 2021 Oct;18(5):247-253. doi: 10.1111/wvn.12526. Epub 2021 Jul 17.
3
Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis.COVID-19住院患者中心房颤动的患病率及影响:一项系统评价和荟萃分析
J Clin Med. 2021 Jun 4;10(11):2490. doi: 10.3390/jcm10112490.
4
Evaluation of Modified ATRIA Risk Score in Predicting Mortality in Hospitalized Patients With COVID-19.评估改良的 ATRIA 风险评分在预测 COVID-19 住院患者死亡率中的作用。
Am J Med Sci. 2021 Dec;362(6):553-561. doi: 10.1016/j.amjms.2021.06.001. Epub 2021 Jun 6.
5
Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients.预先存在的心房颤动与 COVID-19 患者的死亡率增加有关。
J Interv Card Electrophysiol. 2021 Nov;62(2):231-238. doi: 10.1007/s10840-021-00992-2. Epub 2021 Apr 15.
6
Atrial fibrillation in patients with COVID-19. Usefulness of the CHADS-VASc score: an analysis of the international HOPE COVID-19 registry.新型冠状病毒肺炎患者的心房颤动。CHADS-VASc评分的实用性:一项对国际HOPE新型冠状病毒肺炎注册研究的分析
Rev Esp Cardiol (Engl Ed). 2021 Jul;74(7):608-615. doi: 10.1016/j.rec.2020.12.009. Epub 2021 Jan 13.
7
Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19.COVID-19 患者中 CHADS2 和 CHA2DS2-VASc 评分对血栓栓塞事件和死亡率的预测。
Europace. 2021 Jun 7;23(6):937-947. doi: 10.1093/europace/euab015.
8
New onset atrial fibrilation and risk faktors in COVID-19.新型冠状病毒肺炎患者新发心房颤动及其危险因素。
J Electrocardiol. 2021 Mar-Apr;65:76-81. doi: 10.1016/j.jelectrocard.2020.12.005. Epub 2021 Jan 21.
9
New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis.新型冠状病毒感染期间新发心房颤动预示预后不良。
Cardiol J. 2021;28(1):34-40. doi: 10.5603/CJ.a2020.0145. Epub 2020 Nov 3.
10
Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者就诊时的心电图表现和临床转归。
Europace. 2021 Jan 27;23(1):123-129. doi: 10.1093/europace/euaa245.